2023-504782-23-00已完成1 期
A study of how CagriSema works on appetite in people with excess body weight
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 150
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
EU Submission Hub
Scientific
Novo Nordisk A/S
研究点 (1)
Loading locations...
相似试验
招募中
1 期
Investigating how CagriSema, semaglutide and cagrilintide regulate insulin effects in the body of people with type 2 diabetes.2023-509483-20-00Novo Nordisk A/S150
已完成
1 期
A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body WeightObesityNCT06207877Novo Nordisk A/S62
撤回
3 期
A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body WeightNCT07357766Novo Nordisk A/S1,400
招募中
3 期
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 DiabetesDiabetes Mellitus, Type 2NCT07282613Novo Nordisk A/S80
撤回
2 期
A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 DiabetesDiabetes Mellitus, Type 2NCT07357740Novo Nordisk A/S400